Misplaced Seed
When Ectopic Pregnancy Carried a Grave Prognosis
Approximately half of tubal ectopic pregnancies produce little warning before rupture. When symptoms occur, they are often vague — and easily mistaken for more benign conditions.
Before the late nineteenth century, fatal tubal pregnancy was seldom recognized during life and only imperfectly understood afterward. It appeared sporadically in case reports and anatomical collections, rarely diagnosed with confidence and almost never in time to alter the outcome.
One might imagine an eighteenth-century anatomy room in London, within the intellectual orbit of William Hunter. The subject is a woman in her third decade, brought not to confinement but to examination. Those who attended her recall pelvic pain, waves of weakness, and sudden collapse. The surgeon, suspecting inflammation or obstruction, could do little.
At post-mortem the abdomen is opened; dark, unclotted blood escapes. The uterus appears slightly enlarged yet empty. Closer inspection reveals a distended, ruptured fallopian tube containing the remains of an ovum or early embryo. The surrounding cavity tells the rest — hemorrhage sufficient to extinguish life.
Such cases were recorded as curiosities — “a fœtus in the tube,” a misplaced conception. The bleeding was observed, but tubal gestation had not yet taken firm shape in medical thought as a definable and recurrent danger of pregnancy. It belonged chiefly to the dissection table.
A decisive change came in 1883, when surgeon Robert Lawson Tait undertook a planned abdominal operation for ruptured tubal pregnancy, ligating and removing the bleeding source. The patient survived. With that intervention, ectopic pregnancy moved from post-mortem explanation to operative possibility.
As abdominal surgery matured, antisepsis strengthened, anesthesia became routine, and laparotomy grew deliberate rather than desperate. Surgeons learned to control hemorrhage with increasing confidence. Yet even as technique advanced, a fundamental uncertainty remained:
Was the woman pregnant at all?
Before laboratory testing, early pregnancy announced itself subtly. Amenorrhea might be overlooked. Nausea was nonspecific. Pelvic pain suggested many diagnoses. Even the familiar triad of pain, missed menses, and bleeding was neither universal nor definitive. Diagnosis relied on history and touch. Many women with ruptured ectopic pregnancy were thought to suffer from “pelvic inflammation” or “internal hemorrhage of obscure origin.”
Thus the paradox: the knife had grown more capable, but knowledge lagged.
By the early twentieth century, medicine turned to laboratory science. If pregnancy produced measurable change within the body, perhaps that change could be detected at a distance.
The breakthrough came from placental biology. Shortly after implantation, trophoblast cells destined to form the placenta begin secreting human chorionic gonadotropin (hCG) into the maternal circulation — as early as eight to nine days after fertilization, well before pregnancy is clinically apparent.
Get William P Fleming, MD’s stories in your inbox
Join Medium for free to get updates from this writer.
In the 1920s, investigators showed that urine from pregnant women induced ovarian changes in immature mice and rabbits. In 1927, Selmar Aschheim and Bernhard Zondek demonstrated predictable ovarian enlargement in mice after injection of pregnant urine. In 1931, Maurice Friedman adapted the principle to rabbits, creating the method later known as “the rabbit test.”
The rabbit had to be sacrificed so its ovaries could be examined for follicular maturation and corpora lutea. Contrary to popular folklore, the rabbit did not die because the woman was pregnant; it died because dissection was the only way to determine the result.
The assay, however, was relatively insensitive — requiring high concentrations of hCG — and results took two to three days. Greater speed and sensitivity were needed.
They arrived from the water.
In the 1930s, investigators discovered that the African clawed frog, Xenopus laevis, responded strikingly to hCG. When injected with urine from a pregnant woman, a mature female frog ovulated within eight to twelve hours, depositing visible eggs into the water. Known as the Hogben test, the method required no sacrifice; the frogs lived and could be reused. More sensitive and far faster than the rabbit assay, it provided results within a day.
The progression was striking: from bedside conjecture to eggs suspended in water. Sensitivity increased. Time contracted. Diagnosis sharpened. For the physician confronting suspected ectopic gestation, this was not a minor refinement but a decisive advance. Intervention might now occur before rupture rather than after hemorrhage had declared itself.
The frog tank, ingenious as it was, did not mark the end.
By the late 1950s and 1960s, laboratory science turned from animals to immunology. In 1960, Rosalyn Yalow and Solomon Berson developed the radioimmunoassay, allowing hormones to be measured in minute concentrations. By the late 1960s, laboratory immunologic pregnancy tests replaced animal bioassays. Sensitivity increased dramatically; pregnancy could be confirmed earlier than ever before.
In 1971, the first commercial home pregnancy test appeared in the United States. By the mid-1970s, women could test privately, shifting knowledge from hospital bench to bathroom counter. In the 1980s and 1990s, monoclonal antibody technology refined specificity further, enabling detection of very low levels of hCG only days after implantation.
The progression was clear:
1920s — mice in laboratory cages.
1930s — rabbits in hutches, frogs in glass tanks.
1960s — antibodies in laboratory tubes.
1970s — home kits on pharmacy shelves.
1990s and beyond — high-sensitivity immunoassays and digital readouts.
Each advance shortened the interval between conception and certainty. In the context of ectopic pregnancy, that contraction of time has been life-saving. The earlier pregnancy is identified, the sooner its location can be determined.
In the early 1900s, before reliable diagnosis and timely surgery, case-fatality rates for ectopic pregnancy were often estimated at 30–50%, and in some series higher. Even in the first decades of the twentieth century, mortality frequently remained between 5–10%, depending on access to care.
Today, in developed countries, death from ectopic pregnancy is rare. In the United States, it accounts for roughly 2–3% of pregnancy-related deaths, with mortality estimated at approximately 0.1–0.3 deaths per 100,000 live births.
The dramatic improvement in outcomes reflects the convergence of early biochemical detection, high-resolution ultrasound imaging, safe blood transfusion practices, modern anesthesia, minimally invasive surgery, and medical management with methotrexate. What was once recognized only at autopsy is now routinely diagnosed and treated before rupture occurs — sometimes even before symptoms declare themselves.
Clarity, once delayed until catastrophe, is now available at the molecular level.
published first on Substack
